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Abstract 
Purpose: To analyze the relationship between hypercapnia developing within the first 48 h after the start of mechan‑
ical ventilation and outcome in patients with acute respiratory distress syndrome (ARDS).
Patients and methods: We performed a secondary analysis of three prospective non‑interventional cohort studies 
focusing on ARDS patients from 927 intensive care units (ICUs) in 40 countries. These patients received mechanical 
ventilation for more than 12 h during 1‑month periods in 1998, 2004, and 2010. We used multivariable logistic regres‑
sion and a propensity score analysis to examine the association between hypercapnia and ICU mortality.
Main outcomes: We included 1899 patients with ARDS in this study. The relationship between maximum PaCO2 in 
the first 48 h and mortality suggests higher mortality at or above PaCO2 of ≥50 mmHg. Patients with severe hyper‑
capnia (PaCO2 ≥50 mmHg) had higher complication rates, more organ failures, and worse outcomes. After adjusting 
for age, SAPS II score, respiratory rate, positive end‑expiratory pressure, PaO2/FiO2 ratio, driving pressure, pressure/vol‑
ume limitation strategy (PLS), corrected minute ventilation, and presence of acidosis, severe hypercapnia was associ‑
ated with increased risk of ICU mortality [odds ratio (OR) 1.93, 95% confidence interval (CI) 1.32 to 2.81; p = 0.001]. In 
patients with severe hypercapnia matched for all other variables, ventilation with PLS was associated with higher ICU 
mortality (OR 1.58, CI 95% 1.04–2.41; p = 0.032).
Conclusions: Severe hypercapnia appears to be independently associated with higher ICU mortality in patients with 
ARDS.
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Take-home message: Severe hypercapnia appears to be independently 
associated with higher ICU mortality in patients with ARD.
The members of the VENTILA Group are listed in the electronic 
supplementary material (file ESM‑2).
Introduction
Mechanical ventilation (MV) with high tidal volumes has 
been shown to both cause and worsen lung injury [1–3]. 
Hickling et al. [4] reported that during MV of acute res-
piratory distress syndrome (ARDS), limitation of airway 
pressure to <30 cmH2O was associated with lower mor-
tality in patients with acute lung injury. Limitation of 
tidal volumes and airway pressure is now used as a lung 
protective strategy during MV in patients with ARDS. 
However, this strategy can sometimes result in high par-
tial pressure of carbon dioxide in arterial blood (PaCO2) 
levels [5, 6]. In the early 1990s the concept of permis-
sive hypercapnia was proposed for patients with acute 
lung injury. In the ARDS Network Study comparing 
low and high tidal volumes [7], patients in the low tidal 
volume group had only mild changes in PaCO2 (35 ± 8 
vs. 40 ±  10 mmHg), probably due to higher respiratory 
rates in that group. Also, in experimental models of sep-
sis-induced acute lung injury there were reports of the 
beneficial effects of hypercapnic acidosis [8, 9]. It was 
even suggested that “therapeutic hypercapnia” might be 
beneficial [10–12]. However, more recent studies have 
reported that hypercapnia has harmful effects, including 
impairment of alveolar epithelial function, cell prolifera-
tion, and muscle function as well as of neutrophil func-
tion and innate immunity [13–21]. Acute hypercapnia 
may also have significant hemodynamic consequences 
and lead to pulmonary hypertension, right ventricular 
dysfunction, and prolonged bronchopleural leakage [22].
In view of the prevalent paradigm of tolerance of 
hypercapnia in ARDS patients and recent conflicting 
reports on the biologic effects of hypercapnia, we sought 
to evaluate the impact of high PaCO2 on intensive care 
unit (ICU) outcomes in a large cohort of ARDS patients 
subjected to MV.
Methods
Patients
We conducted a secondary analysis of data from 18,302 
patients admitted to 927 ICUs in 40 countries who were 
enrolled in one of three international prospective, multi-
center, non-interventional, observational studies carried 
out in 1998, 2004, and 2010 [23–25] and had received 
MV for >12 h during a 1-month period. The research eth-
ics committee of each participating institution approved 
the study protocol. For the purpose of this study, we 
selected patients who received invasive MV for more 
than 24  h because of ARDS or who developed ARDS 
after the first 24 h of MV. ARDS was defined by the cri-
teria established by the American–European Consensus 
Conference: acute onset, PaO2/fraction of inspirted oxy-
gen (FiO2) of <200  mmHg, bilateral infiltrates on chest 
radiograph, absence of heart failure, and diagnosis of 
ARDS by the clinician in charge. We considered these 
patients to have moderate or severe ARDS according to 
the Berlin definition.
We collected baseline characteristics, the first arterial 
blood gas measurement and the corresponding ventila-
tor settings, daily gas exchange, clinical management, 
and complications while patients were being ventilated 
or until day 28. If several arterial blood gas measure-
ments were available for the same patient during the first 
24 h of MV, we used the worst PaCO2 value during this 
period for analysis. Hospital mortality and length of stay 
were documented. A full description of the methodology 
has been published previously [25]. Our primary objec-
tive was to assess the independent effect of PaCO2 on 
ICU mortality rate in patients with ARDS. The secondary 
objectives were to determine the effects of PaCO2 on ICU 
length of stay, hospital length of stay, and complications 
over the course of MV.
Statistical analysis
Data are expressed as the mean ± standard deviation, 
the median with the interquartile range, and proportions 
(absolute and relative frequencies) as appropriate. Student’s 
t test or the Mann–Whitney test was used to compare con-
tinuous variables, while the χ2 test or Fisher’s exact test was 
used to compare proportions. A p value of <0.05 was con-
sidered to show a statistically significant difference.
Maximum PaCO2 in the first 48  h after initiation of 
MV was categorized into six groups (<30, 30–39, 40–49, 
50–59, 60–69, and >70 mmHg); the cutoffs corresponded 
approximately to the 5th, 35th, 70th, 85th, and 95th per-
centiles of higher PaCO2 within 48  h after the diagno-
sis of ARDS, respectively. The groups with a PaCO2 of 
30–39 and 40–49 mmHg had the lowest ICU mortality. 
PaCO2 values associated with significantly increased ICU 
mortality were defined as “severe hypercapnia”. We also 
performed recursive partitioning, showing the effects 
of hypercapnia and hypocapnia (defined as PaCO2 > 
30 mmHg) on ICU mortality.
To assess the independent effect of hypercapnia on 
outcome (ICU mortality), we performed a full univariate 
analysis of the association between relevant illness sever-
ity variables and ICU mortality. A maximum model was 
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then constructed by performing a predictive multivariate 
logistic regression model, including all variables selected 
in the univariate analysis that were measured in 80% of 
patients and showed a significant statistically associa-
tion (p < 0.10) in the univariate analysis. Thus, the final 
model was chosen based on the highest area under the 
receiver operating characteristic curve after backward 
elimination of non-significant variables. Moreover, some 
other variables were included in a full multivariate model 
to explore unmeasured confounders probably related 
with ICU mortality, such as driving pressure [defined 
as plateau pressure minus positive end-expiratory pres-
sure (PEEP)] and the use of a pressure/volume limitation 
strategy (PLS). This was defined by consensus as a tidal 
volume of <8 ml/kg of actual body weight and a plateau 
pressure or peak inspiratory pressure of <30 cmH2O [24]. 
Because clinical practices regarding MV strategies in 
patients diagnosed with ARDS have changed over time, 
the model was also adjusted for the period of the study. 
In addition, because dead space is strongly associated 
with mortality [26] and may be a confounding factor for 
hypercapnia, we calculated the corrected minute ventila-
tion (VEcorr) for a normal PaCO2 (calculated as minute 
ventilation × actual PaCO2/40 mmHg) as a surrogate for 
dead space [27] and introduced this as a co-variable into 
the univariate and multivariate model. We created a ver-
tical plot showing the adjusted odds ratio (OR) for ICU 
mortality and PaCO2 as categorized.
Interactions between hypercapnia and acidosis, dead 
space, and PLS, respectively, were tested by logistic 
regression. We considered a p value of <0.2 to show sta-
tistically significant interaction [Electronic Supplemen-
tary Material (ESM) Fig. E2]. The potentially non-linear 
relationship of the variable was tested by the use of frac-
tional polynomials. Standard errors were calculated by 
1000 bootstrap resampling as a validation analysis.
As a sensitivity analysis and to explore the effect of 
severe hypercapnia under the most unfavorable clini-
cal conditions, which are present in those patients sub-
jected to protective ventilation where the development 
of hypercapnia may be a severity marker with a contra-
dictory effect on ICU mortality and therefore may serve 
as a confounder variable, we used logistic regression to 
develop a propensity score model in order to estimate the 
relationships between severe hypercapnia and ICU mor-
tality in patients ventilated with <8 ml/kg. The log odds of 
the probability that a patient had severe hypercapnia (the 
logit) were modeled as a function of the confounders by 
logistic regression that we identified and included in our 
data set. We then performed a one-to-one matched anal-
ysis without replacement on the basis of the estimated 
propensity score (likelihood of developing severe hyper-
capnia) of each patient. A nearest-neighbor-matching 
algorithm was used to match patients on the basis of their 
hypercapnia status (present or absent) and the logit of 
their propensity score, with matching occurring if the dif-
ference in the propensity scores was <0.2-fold the stand-
ard deviation of the logit (the caliper width). We selected 
0.2 because this value has been shown to eliminate 
approximately 90% of the bias in observed confound-
ers [28]. We estimated standardized differences for all 
covariates before and after matching, with a standardized 
difference of ≥10% considered to be indicative of imbal-
ance [29]. All subsequent analyses were performed in 
the matched sample, using methods appropriate for the 
analysis of matched data to estimate the average treat-
ment effect as the difference in outcome (ICU mortality) 
among the exposed group (severe hypercapnia) and the 
matched unexposed cohort (without severe hypercap-
nia) [30]. We calculated bootstrapped standard errors 
to generate 95% confidence intervals (CI). After match-
ing, variables showing an unbalanced result (defined as 
a standardized difference of >10%) were introduced into 
the propensity score as non-linear terms. If these varia-
bles kept a standardized difference of >10%, a generalized 
estimating equation model was fitted adding them.
Statistical analyses were performed using IBM SPSS 
software (ver. 21.0; IBM Corp., Armonk, NY) and Stata 
software (ver. 13.1; StataCorp LP, College Station, TX).
Results
Overall, 1899 patients with ARDS were included in the 
analysis. Figure 1 shows the study flow chart. 
PaCO2 values within the first 48 h of MV and ICU mortality
Mortality was significantly higher in patients with a max-
imum PaCO2 of ≥50 mmHg during the first 48 h of MV 
than in patients with a maximum PaCO2 of <50 mmHg 
(Table 1; ESM Fig. E1). In order to verify this result, we 
performed logistic regression with data adjusted by age, 
Simplified Acute Physiology Score (SAPS) II score at ICU 
admission, PaO2/FiO2 ratio, PEEP, respiratory rate, aci-
dosis, the use of a PLS during the first 48  h after start-
ing MV, and the period of the study, using a PaCO2 of 
40–49  mmHg as the reference category. This analysis 
confirmed significantly higher ICU mortality with higher 
maximum PaCO2 values (Fig. 2). 
We thus defined “severe hypercapnia” as a PaCO2 of 
≥50  mmHg. Overall, ICU mortality for the patients 
included in the analysis was 53% (999/1899).
Clinical characteristics of patients with severe hypercapnia
Patients with severe hypercapnia were more likely to be 
male. Severe hypercapnia was significantly more frequent 
in patients with ARDS during the last two time periods 
(1998 vs. 2004, p  <  0.01; 1998 vs. 2010, p  <  0.001) and 
higher in the last period (2004 vs. 2010, p  <  0.01). The 
PaO2/FiO2 ratio was significantly lower in patients with 
severe hypercapnia, and peak airway pressure, plateau 
airway pressure, and PEEP were higher in patients with 
severe hypercapnia (Table 2).
Clinical events over the course of MV and outcomes
Patients with severe hypercapnia had more complications 
and more organ dysfunctions over the course of MV 
than those without severe hypercapnia, including baro-
trauma, renal dysfunction, and cardiovascular dysfunc-
tion (Table 3). The univariate analysis of the association 
between relevant illness severity variables and clinical 
outcome (status at ICU discharge) showed that PaCO2 
values were statistically significantly higher in non-survi-
vors than in survivors (ESM Table E1).
Patients with and without severe hypercapnia had 
similar durations of MV and similar lengths of ICU stay 
(Table  3). Crude ICU mortality was significantly higher 
in patients with severe hypercapnia than in those without 
severe hypercapnia (62.5 vs. 49.6%).
Relationship between hypercapnia and ICU mortality
In univariate analysis, severe hypercapnia was associ-
ated with an increased risk of ICU mortality (OR 1.68, 
95% CI 1.35–2.10; p ≤ 0.001). After adjustment for base-
line variables, including age, SAPS II at ICU admission, 
VEcorr, use of PLS, presence of acidosis, driving pres-
sure, PaO2/FiO2 ratio, and study period, the presence of 
severe hypercapnia remained independently associated 
with a higher risk for ICU mortality (OR 1.93, 95% CI 
1.32–2.81; p = 0.001) (Table 4). The effect was consistent 
taking the PaCO2 as a continuous variable and adjusting 
for the same co-variables as above (Fig. 2). Importantly, 
acidosis or the combination of hypercapnia and acido-
sis independently increased the risk of ICU mortality, 
although no statistically significant interaction between 
these two factors was identified (p = 0.28; ESM Fig. E2). 
We found no significant interaction with PLS or VEcorr 
(p = 0.28 and p = 0.64, respectively). Based on the effect 
of acidosis on severe hypercapnia and ICU mortality, we 
finally developed an adjusted binomial logistic model 
including all previous variables (age, SAPS II at ICU 
admission, PEEP, VEcorr, LPS ventilatory strategy, driving 
pressure, respiratory rate, PaO2/FiO2 ratio, hematological 
Fig. 1 Study flow chart. ARDS Acute respiratory distress syndrome, 
MV mechanical ventilation, PaCO2 partial pressure of carbon dioxide 
in arterial blood
Table 1 Univariate analysis of  the relationship 
between  partial pressure of  carbon dioxide in  arterial 
blood and mortality in the intensive care unit
Values are presented as the number with the percentage in parenthesis unless 
indicated otherwise
PaCO2 partial pressure of carbon dioxide in arterial blood, CI confidence interval 
PaCO2 (mmHg) N = 1899  
patients
Odds ratio  
(95% CI)
p value
≤30 144 (7.6) 1.77 (1.22–2.56) 0.002
30–39.9 732 (38.5) 1.07 (0.86–1.32) 0.522
40–49.9 635 (12.2) 1.0 –
50–59.9 232 (12.2) 1.69 (1.25–2.30) 0.001
60–69.9 87 (4.6) 1.79 (1.13–2.84) 0.013
>70 69 (3.6) 2.88 (1.66–5.00) <0.001
Fig. 2 Adjusted effects of PaCO2 at 48 h from the beginning of the 
period of mechanical ventilation on mortality in the intensive care 
unit (ICU). Each black square represents the odds ratio for each PaCO2 
interval adjusted by age, Simplified Acute Physiology Score II score, 
PaO2/fraction of inspirted oxygen (FiO2) ratio, pressure/volume limita‑
tion strategy, respiratory rate, presence of acidosis, dead space, and 
year of study, solid vertical lines 95% confidence intervals, horizontal 
dotted line threshold between non‑significant and significant differ‑
ences (odds ratio = 1)
Table 2 Comparison between  patients with  and without  severe hypercapnia and  patients with  no hypercapnia dur-
ing the first 2 days of mechanical ventilation
Values in table are presented as the mean with the standard deviation (SD) in parenthesis, unless indicated otherwise
ABW Actual body weight, FiO2 fraction of inspired oxygen PEEP positive end-expiratory pressure SAPS Simplified Acute Physiology Score, VEcorr corrected minute 
ventilation
Basal characteristics Severe hypercapnia (PaCO2 ≥ 50 mmHg) 
(N = 432 patients)
No severe hypercapnia (PaCO2 < 
50 mmHg) (N = 1467 patients)
p value
Age (years) 56.3 (17.1) 57.0 (17.3) 0.282
Male sex [n (%)] 298 (69.1%) 899 (61.4%) 0.004
SAPS II (points) 49.5 (19.2) 48.1 (17.8) 0.319
Year of study [n (% period)]
  1998 89 (20.6%) 387 (26.4%)
  2004 139 (322%) 499 (34.0%) 0.477
  2010 204 (47.2%) 581 (39.6%) 0.005
Arterial blood gases on day 1
  pH 7.31 (0.11) 7.37 (0.09) <0.001
  PaCO2 (mmHg) 60.6 (11.5) 38.7 (6.1) <0.001
  PaO2/FiO2 ratio 141.3 (75.4) 185.4 (92.8) <0.001
Ventilatory settings on day 1
  Respiratory rate) 21.3 (7.0) 18.8 (5.9) <0.001
  Tidal volume (ml/kg ABW) [n (%)] <0.001***
    <6 137 (33.8%) 268 (19.2%) <0.001
    6–8 234 (57.8%) 960 (68.7%) <0.001
    >8 34 (8.4%) 169 (12.1%) <0.01
  PEEP (cmH2O) 9.4 (4.6) 7.6 (4.4) <0.001
  Peak airway pressure (cmH2O) 32.9 (8.5) 29.7 (7.8) <0.001
  Plateau airway pressure (cmH2O) 26.3 (6.6) 23.5 (6.3) <0.001
  Driving pressure (cmH2O) 16.3 (6.6) 15.8 (6.6) 0.233
  Pressure/volume limitation strategy [n 
(%)]
115 (30.1%) 266 (69.8%) <0.001
  VEcorr (l/min) 14.2 (5.9) 9.2 (3.3) <0.001
Table 3 Descriptive analysis of  the complications and  clinical outcomes of  patients over  the course of  the period 
of mechanical ventilation
Values in table are presented as the number of patients with the percentage in parenthesis or as the median with the interquartile range (p25, p75) in parenthesis, as 
appropriate 
Complications Severe hypercapnia (PaCO2 ≥ 50 mmHg) 
(N = 432 patients)
No severe hypercapnia (PaCO2 < 50 mmHg) 
(N = 1467 patients)
p value
Barotrauma 47 (10.9%) 91 (6.%) 0.001
Sepsis 247 (57.2%) 809 (55.1%) 0.456
Ventilator‑associated pneumonia 116 (26.9%) 384 (26.2%) 0.779
Cardiovascular failure 321 (74.3%) 964 (65.7%) 0.001
Renal failure 151 (35.0%) 421 (28.7%) 0.013
Hepatic failure 62 (14.4%) 212 (14.5%) 0.959
Hematological failure 117 (27.1%) 403 (27.5%) 0.874
Duration of MV (days) 8 (4, 15) 8 (4, 14) 0.405
Length of ICU stay (days) 12 (6, 21) 12 (6, 21) 0.548
Length of hospital stay (days) 19 (9, 35) 20 (11, 35) 0.366
ICU mortality 270 (62.5%) 729 (49.6%) <0.001
failure, and study period). We omitted acidosis in order 
to avoid overadjustment because an interaction remained 
between acidosis and hypercapnia. The model indicated 
that severe hypercapnia was markedly and independently 
associated with a higher risk of ICU mortality (OR 2.40, 
95% CI 1.67–3.46; p < 0.001) (ESM Tables E2 and E3).
After propensity-score matching (see ESM Table E4 
and ESM Fig. E3 for the quality of the matching process), 
there was a significant difference in the effect of severe 
hypercapnia on ICU mortality between patients receiving 
tidal volumes of <8 ml/kg (n = 344) and those receiving 
tidal volumes of >8  ml/kg (risk-adjusted ICU mortality: 
OR 1.58, 95% CI 1.04–2.41; p = 0.032).
Discussion
After multiple adjustments and propensity analysis, we 
found that severe hypercapnia was independently associ-
ated with ICU mortality, with higher rates of organ dys-
function and more complications during MV in patients 
with moderate or severe ARDS. These findings may have 
clinical implications. The association between hypercap-
nia and complications during MV in unadjusted analyses 
may be a function of worse lung injury, but after multi-
variate adjustment hypercapnia was still associated with 
ICU mortality in ARDS patients.
The use of permissive hypercapnia is based on obser-
vational reports in the 1990s suggesting that lower tidal 
volumes during MV were associated with better survival. 
However, no independent studies of the specific effects of 
hypercapnia on outcome were performed [4, 5]. In a sub-
sequent study of 49 preterm infants, there was no differ-
ence in mortality between patients with hypercapnia and 
those with normocapnia [30], leading to the conclusion 
that permissive hypercapnia was safe but not protective. 
In a secondary analysis of data from the ARDS Network 
Study [31], the authors reported that the presence of 
hypercapnic acidosis (defined as pH of <7.35 and PaCO2 
of >45  mmHg) at the time of randomization, based on 
multivariate logistic regression analysis and controlling 
for other comorbidities and severity of lung injury, was 
associated with lower 28-day mortality only in patients 
randomized to a tidal volume of 12  ml/kg. The authors 
found no effect on mortality among patients randomized 
to 6  ml/kg tidal volume. The study was limited by the 
small number of patients included in each subgroup and 
showed no difference in the patients with “protective 
ventilation”, where hypercapnia was expected to occur.
In our study, patients receiving lung-protective ventila-
tion with a tidal volume of ≤6 ml/kg actual body weight 
had a high incidence of severe hypercapnia (Table 2) due 
to the lower tidal volume and subsequent reduction in 
alveolar ventilation. High ventilation/perfusion (V/Q) 
areas and higher dead space could also increase the level 
of hypercapnia due to more severe lung injury (Table 2). 
A correlation between high dead space and mortality 
has been found in patients with ARDS [26]. Therefore, 
in our analysis, we used the “corrected minute ventila-
tion” (VEcorr) as a surrogate for dead space [27] and found 
that even after adjusting for VEcorr, severe hypercapnia 
remains strongly associated with mortality. Moreover, 
Brown et  al. [32] showed that a minute ventilation of 
>13.9 l/min was an important predictor of hospital mor-
tality at 90 days in acute lung injury, similar to our find-
ings (>14 l/min).
Initial studies in animal models of ventilator-induced 
lung injury and sepsis reported beneficial effects of 
hypercapnia, which supported the notion of “permissive” 
hypercapnia for patients with lung injury [8, 9]. More 
recent studies have reported that high levels of PaCO2 
activate specific signaling pathways, independently of 
pH or reactive oxygen species, leading to impaired lung 
function [19, 33, 34]. Furthermore, in a model of ventila-
tor-induced lung injury the probability of wound repair 
was significantly reduced in hypercapnic conditions 
[9]. This concept was further explored in a study where 
hypercapnia caused mitochondrial stress via the activa-
tion of microRNA (miR)-183, which by downregulating 
isocitrate dehydrogenase 2 had a detrimental effect on 
cell proliferation, which could explain impaired wound 
repair [18, 19]. It has also been reported that hypercapnia 
impairs innate immunity in Drosophila melanogaster [16] 
by decreasing the expression of antimicrobial peptides, 
and hypercapnia was observed to increase mortality in 
a mouse model of Pseudomonas aeruginosa pneumonia 
[20]. In addition, elevated CO2 levels have been found to 
contribute to increased bacterial and fungal virulence, 
which may render hypercapnic tissues more susceptible 
to infection [35–38]. These and other recently reported 
data suggest that hypercapnia impairs innate immu-
nity via evolutionarily conserved mechanisms [17] and 
explain why patients exposed to hypercapnia have an 
impaired ability to fight infection. Furthermore, hyper-
capnia has hemodynamic consequences, increasing pul-
monary hypertension and worsening right ventricular 
Table 4 Multivariate analysis to  evaluate the adjusted 
effect of  hypercapnia on  mortality in  the intensive care 
unit
Severe hypercapnia Mortality in the intensive care 
unit
p value
N Odds ratio 95% CI
Crude 1899 1.68 1.35–2.10 0.000
Adjusted 1137 2.40 1.67–3.46 0.000
After matching 342 1.58 1.04–2.41 0.032
function [38]; these effects are associated with worse out-
comes in patients with acute lung injury [38–41].
The relationship between PaCO2 and ICU mortality 
describes a U-shaped curve (Fig.  2). Higher mortality 
at low PaCO2 may suggest relative hyperventilation and 
prevalence of lung regions with a high V/Q value and 
potentially ventilator-induced lung injury. Recent data 
show that hypocapnia is associated with worse outcome 
in patients with pneumonia [36, 33], although no data 
from ARDS patients are available.
Our study provides new information showing that 
hypercapnia appears to be independently associated 
with worse outcomes in patients with ARDS. This find-
ing raises the question of whether the previously pro-
posed paradigm that hypercapnia has a protective effect 
in patients with lung injury is safe, at least above a certain 
range.
Our study is a multinational survey that reflects MV 
practice worldwide in a real-life setting. Moreover, the 
prospective non-interventional design reveals, for the 
first time, an independent association between severe 
hypercapnia and ICU mortality of mechanically venti-
lated ARDS patients from ICUs in 40 countries. How-
ever, the study also has a number of limitations. First, the 
data derive from an observational study that was not pri-
marily designed to test a specific hypothesis. Only 1899 
of a possible total of 18,302 patients were analyzed (only 
recognized ARDS patients), and the numbers of patients 
in the hypercapnia categories were quite small. Further-
more, arterial blood gases and patient–ventilator inter-
action parameters were documented once daily, and a 
single measurement each day may have been insufficient 
to reflect the full respiratory progression throughout the 
day. However, data collection was always performed at 
the same time of day. Many patients had to be excluded 
from the analysis because arterial blood gas data were 
missing (11.5%; 2114/18,302 patients recruited). Another 
limitation is the absence of hemodynamic assessment. 
Finally, the causal inferences that can be drawn from 
observational studies are necessarily limited. Despite 
adjustment for oxygenation and use of a surrogate for 
dead space, unmeasured confounders could influence the 
relationship between hypercapnia and ICU mortality. By 
matching patients that were ventilated with tidal volumes 
of <8 ml/kg, we performed propensity-score matching as 
a sensitivity analysis, and the effect of severe hypercap-
nia was consistent. We explored interactions between 
PLS strategy and dead space, and ARDS patients with 
hypercapnia still showed higher ICU mortality. We have 
detected a consistent effect of severe hypercapnia after 
dismissing known confounders, such as the presence of 
acidosis or a protective ventilation strategy. Also, an inde-
pendent deleterious effect of acidosis on ICU mortality 
was observed, although the independent effect of severe 
hypercapnia remained even in those ARDS patients who 
developed acidosis. Therefore, the adjusted risk of ICU 
mortality in ARDS patients with severe hypercapnia did 
not include the presence of acidosis in order to avoid 
over-adjustment [34].
 In summary, the results in these cohorts of mechani-
cally ventilated patients with ARDS suggest that severe 
hypercapnia within the first 48 h of MV is independently 
associated with higher ICU mortality. Our data also show 
that these patients have more ventilator-related com-
plications. Despite our efforts to adjust for the factors 
involved in the causal chain between severe hypercapnia 
and ICU mortality, we cannot rule out the presence of 
unmeasured confounders, arising from the observational 
and non-interventional study design that may interfere 
with the results. Indeed, the findings have to be inter-
preted as a possible biological signal that requires con-
firmation by clinical trials specifically designed for this 
purpose. Overall, the data reported here may serve as a 
first step towards defining possible limits for hypercap-
nia. In the absence of strong evidence, our findings may 
provide some guidance for reasonable limits of PaCO2 for 
ARDS patients in the ICU and also for potential reassess-
ment of the previous assumption that severe hypercapnia 
is safe.
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